O-28: Endometriosis Is Influenced by The Promoter Haplotype-Based Expression of Macrophage Migration Inhibitory Factor (MIF)

Authors

  • Afsharian P
  • Aghajanpour S
  • Ramezanali F
  • Shahhoseini M
Abstract:

Background: Macrophage migration inhibitory factor (MIF) is a key pro-inflammatory cytokine that is secreted by accumulated active macrophages in ectopic tissue of endometriosis. MIF is involved in pathophysiological events of endometriosis, such as angiogenesis and cell proliferation. MIF that stimulates the synthesis of PGE2, leads to over-expression of local estradiol synthesis in endometriosis. Materials and Methods: Genomic DNA of 70 patients with endometriosis, who had undergone laparoscopy during 2012- 13, and 70 fertile women were amplified via PCR. Restriction fragment length polymorphism which was applied to determine -173G/C polymorphism. ORF polymorphisms and -794(CATT)5-8 were detected by sequencing. Q- PCR was performed for mRNA expression level of MIF in 14 ectopic tissues. Statistical analysis was done by Chi-square test and one way ANOVA. Results: The genotype analysis of ORF polymorphisms revealed three SNPs: +254, rs2096525 (p=0.84), +656, rs2070766 (p=0.88),+626, rs33958703 (p=0.04). Homozygocity of -794(CATT)5, as normal type, was only observed in control group. Promoter haplotype (-173G/C and -794(CATT)5-8) was different in control and patient groups. Expression level of MIF in ectopic tissues with -794(CATT)6,7/- 173GC was significantly more than the other haplotypes (p=0.00) and in -794(CATT)6,6/-173GC group was significantly higher than -794(CATT)5,5/-173G (p=0.02). We found maximum prevalence of endometriosis at those being 26-30 years. Obese women with BMI≥30 have shown lower risk of endometriosis (p=0.00). Conclusion: We report for the first time, both increased number of CATT repeat in -794 and presence of -173 C in ectopic tissue of endometriosis stimulated MIF promoter activity. It seems haplotype of -794(CATT)5-8/-173G/C and +626 rs33958703 SNP were significantly correlated with susceptibility of endometriosis that might play an important role in pathophysiology of endometriosis.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

I-43: Expression Profile of Macrophage Migration Inhibitory Factor (MIF) Signaling Pathway as A Potentional Biomarker in Pathophysiology of Endometriosis

Background MIF via its receptor, CD74, initiates a signaling cascade that leads to proliferation and survival of cells. Also, MIF binding to CD74 activates p38 signaling pathways that lead to positive effect on the expression of COX-2. The aim of this study was to evaluate the gene expression profile of MIF, CD74 and COX-2 in normal, ectopic and eutopic endometrium during menstrual cycle. The e...

full text

Correlation between urine macrophage migration inhibitory factor (MIF)/creatinine ratio and time after kidney transplantation

 Abstract  Background: Despite the long-standing association of macrophage migration inhibitory  factor (MIF) with delayed-type hypersensitivity response, the potential role  of MIF in chronic allograft nephropathy is unknown. The association between upregulation of MIF expression, macrophage and T cell infiltration and the severity of  chronic allograft nephropathy suggests that MIF may be an ...

full text

Current developments of macrophage migration inhibitory factor (MIF) inhibitors.

The cytokine macrophage migration inhibitory factor (MIF) is regarded as a major regulator of inflammation and a key mediator that counter-regulates the inhibitory effects of glucocorticoids within the immune system. Therefore, MIF is a therapeutic target for the treatment of inflammatory and autoimmune diseases. In addition, MIF was found to be implicated in cancer pathogenesis. Current therap...

full text

Macrophage migration inhibitory factor (MIF), a role in COPD

Authors: 5 Gunnar R. Husebø, Per S. Bakke, Rune Grønseth, Jon A. Hardie, Thor Ueland, Pål 6 Aukrust, Tomas M.L. Eagan. 7 8 Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen Norway 9 2 Dept. of Clinical Science, University of Bergen, Norway 10 Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway 11 K.G. Jebsen Inflammatory Research Centre...

full text

Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.

The cytokine macrophage migration inhibitory factor (MIF) possesses unique tautomerase enzymatic activity, which contributes to the biological functional activity of MIF. In this study, we investigated the effects of blocking the hydrophobic active site of the tautomerase activity of MIF in the pathogenesis of lung cancer. To address this, we initially established a Lewis lung carcinoma (LLC) m...

full text

Human Macrophage Migration Inhibitory Factor (mif): a Proven Immunomodulatory Cytokine?

HUMAN MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF): A PROVEN IMMUNOMODULATORY CYTOKINE? Alex Kudrin‡, Martin Scott§, Steven Martin§, Chun-wa Chung§, Rachelle Donn¶¥, Andrew McMaster¥, Stuart Ellison¥, David Ray¶, Keith Ray‡, Michael Binks‡ From the ‡Department of Disease Biology, Rheumatology and Inflammation, GlaxoSmithKline, Stevenage, United Kingdom, SG1 2NY. §Discovery Research, GlaxoSmithK...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 8  issue 2.5

pages  26- 26

publication date 2014-07-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023